Publication | Open Access

Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups

Catalytic DomainBiochemistryCatechol GroupsMedicineAntiviral Drug DevelopmentAntiviral TherapyResistance Mutation (Virology)Antiviral DrugHivPharmacologyAntiviral CompoundHiv-1 Integrase InhibitorsDrug Discovery